Key facts
- Bovotica’s last known valuation is $9.4M (May 2025).
- It has raised $3.4M; the latest was Seed Round ($3.4M) in May 2025.
- Notable investors include SparkLabs Group, AgriZeroNZ, InnovationClub, Lord Pastoral, Melt Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Bovotica
- ·The full record, as it builds
Funding rounds
No funding rounds for Bovotica are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bovotica
Developer of a microbiome modulation technology designed to reduce methane emissions and improve livestock productivity. The company offers precision-targeted microbial interventions, enabling cattle farmers to achieve greater environmental sustainability and production efficiency.
- Sector
- Healthcare
- HQ
- Brisbane, Australia
- Founded
- 2023
- Employees
- 6
- Website
- bovotica.com/
- Ownership
- Privately Held (backing)
Bovotica doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bovotica shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bovotica in its N-PORT filings yet. We sweep new filings monthly.